Biotech Giant Amgen Keeps Falling, Here’s The Trade

The stock is now trading below its important 200-day moving average. This puts the stock in a weak technical position on the charts. It also indicates lower prices ahead for the shares.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.